{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:51:56Z","timestamp":1781790716925,"version":"3.54.5"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>PRDM1 is a key transcriptional repressor that plays a vital role in B- and T-cell differentiation, immune regulation, and tumor suppression. PRDM1 functions through its C2H2 zinc finger domains and proline-rich region, which mediate transcriptional repression by recruiting co-repressors like G9a and HDACs. Its expression is regulated by multiple signaling pathways, including JAK\/STAT3 and CD40L, which control immune cell differentiation and function. PRDM1 is involved in cancer progression by regulating tumor suppression and metastasis, as seen in hepatocellular, colorectal, and breast cancers. Additionally, PRDM1 is implicated in autoimmune diseases such as lupus and rheumatoid arthritis, where it modulates B-cell differentiation and immune responses. Emerging evidence suggests that single nucleotide polymorphisms in the PRDM1 could serve as valuable biomarkers for disease diagnosis and prognosis. This review highlights the multifaceted roles of PRDM1 in disease pathogenesis and explores its potential as a therapeutic target for cancer and immune-related diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1856181","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:02:07Z","timestamp":1781787727000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["PRDM1-mediated epigenetic and transcriptional repression mechanisms: a key hub in immune differentiation, tumor progression, and inflammatory responses"],"prefix":"10.3389","volume":"17","author":[{"given":"Zongliang","family":"Xu","sequence":"first","affiliation":[{"name":"School of Clinical Medicine (Affiliated Hospital), Jining Medical University","place":["Jining, Shandong, China"]},{"name":"Shandong Provincial Precision Medicine Laboratory for Chronic Non-communicable Diseases, Institute of Precision Medicine, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine (Affiliated Hospital), Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhuo","family":"Fu","sequence":"additional","affiliation":[{"name":"Shandong Provincial Precision Medicine Laboratory for Chronic Non-communicable Diseases, Institute of Precision Medicine, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Blood Transfusion Department, Affiliated Hospital of Jining Medical University, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Shen","sequence":"additional","affiliation":[{"name":"Shandong Provincial Precision Medicine Laboratory for Chronic Non-communicable Diseases, Institute of Precision Medicine, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine (Affiliated Hospital), Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.5.5.868","article-title":"Identification and characterization of a novel repressor of beta-interferon gene expression","volume":"5","author":"Keller","year":"1991","journal-title":"Genes Dev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0092-8674(94)90321-2","article-title":"Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells","volume":"77","author":"Turner","year":"1994","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90565-7","article-title":"Blimp-1 is the murine homolog of the human transcriptional repressor PRDI-BF1","volume":"78","author":"Huang","year":"1994","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.26.021607.090241","article-title":"Regulation and functions of Blimp-1 in T and B lymphocytes","volume":"26","author":"Martins","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.gde.2016.03.009","article-title":"The role of PRDMs in cancer, one family, two sides","volume":"36","author":"Mzoughi","year":"2016","journal-title":"Curr Opin Genet Dev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1996.0516","article-title":"The B-lymphocyte maturation promoting transcription factor BLIMP1\/PRDI-BF1 maps to D6S447 on human chromosome 6q21-q22.1 and the syntenic region of mouse chromosome 10","volume":"37","author":"Mock","year":"1996","journal-title":"Genomics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106011","article-title":"The identification and structure of an N-terminal PR domain show that FOG1 is a member of the PRDM family of proteins","volume":"9","author":"Clifton","year":"2014","journal-title":"PloS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e100010","DOI":"10.3390\/ijms19103250","article-title":"PR\/SET domain family and cancer, novel insights from the Cancer Genome Atlas","volume":"19","author":"Sorrentino","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e106011","DOI":"10.1371\/journal.pone.0106011","article-title":"The identification and structure of an N-terminal PR domain show that FOG1 is a member of the PRDM family of proteins","volume":"9","author":"Clifton","year":"2014","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"16522","DOI":"10.3390\/ijms242216522","article-title":"Cancer associated PRDM9, implications for linking genomic instability and meiotic recombination","volume":"24","author":"Ladias","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1242\/dev.070110","article-title":"The Prdm family, expanding roles in stem cells and development","volume":"139","author":"Hohenauer","year":"2012","journal-title":"Development"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/35065138","article-title":"Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain","volume":"410","author":"Bannister","year":"2001","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ni1046","article-title":"PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing","volume":"5","author":"Gyory","year":"2004","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.1.125","article-title":"PRDI-BF1\/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins","volume":"13","author":"Ren","year":"1999","journal-title":"Genes Dev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.20.7.2592-2603.2000","article-title":"Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase","volume":"20","author":"Yu","year":"2000","journal-title":"Mol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.08.032","article-title":"Epigenetic modifications induced by Blimp-1 regulate CD8+ T cell memory progression during acute virus infection","volume":"39","author":"Shin","year":"2013","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.15.1924","article-title":"Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation","volume":"13","author":"Zhang","year":"1999","journal-title":"Genes Dev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3349","article-title":"Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation","volume":"17","author":"Minnich","year":"2016","journal-title":"Nat Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"dev181107","DOI":"10.1242\/dev.181107","article-title":"PRDM1 controls the sequential activation of neural, neural crest and sensory progenitor determinants","volume":"146","author":"Prajapati","year":"2019","journal-title":"Development"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.6.3125","article-title":"Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines","volume":"170","author":"Gy\u00f6ry","year":"2003","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.994181","article-title":"Methylation contributes to imbalance of PRDM1\u03b1\/PRDM1b\u03b2 expression in diffuse large B-cell lymphoma","volume":"56","author":"Zhang","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2008.04.010","article-title":"Activation-dependent induction of blimp-1","volume":"20","author":"Calame","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(03)00267-x","article-title":"Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells","volume":"19","author":"Shapiro-Shelef","year":"2003","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201042","article-title":"High rate of antibody secretion is not integral to plasma cell differentiation as revealed by XBP-1 deficiency","volume":"189","author":"Taubenheim","year":"2012","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.22.13.4771-4780.2002","article-title":"Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells","volume":"22","author":"Lin","year":"2002","journal-title":"Mol Cell Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.23.21.7448-7459.2003","article-title":"XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response","volume":"23","author":"Lee","year":"2003","journal-title":"Mol Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5312.596","article-title":"Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation","volume":"276","author":"Lin","year":"1997","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.7.4805","article-title":"STAT3-mediated up-regulation of BLIMP1 is coordinated with BCL6 down-regulation to control human plasma cell differentiation","volume":"180","author":"Diehl","year":"2008","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ni1357","article-title":"Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination","volume":"7","author":"Klein","year":"2006","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-518605","article-title":"Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation","volume":"123","author":"Huang","year":"2014","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2010.257","article-title":"Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch","volume":"29","author":"Muto","year":"2010","journal-title":"EMBO J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1038\/s41467-023-39734-5","article-title":"Toll-like receptor mediated inflammation directs B cells towards protective antiviral extrafollicular responses","volume":"14","author":"Lam","year":"2023","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"12078","DOI":"10.1038\/s41598-017-12171-3","article-title":"Differential regulation of effector and regulatory T cell function by Blimp1","volume":"7","author":"Bankoti","year":"2017","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.immuni.2009.05.014","article-title":"Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties","volume":"31","author":"Rutishauser","year":"2009","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111174","article-title":"STAT5 is a potent negative regulator of TFH cell differentiation","volume":"209","author":"Johnston","year":"2012","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2013.04.003","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.06.021","article-title":"Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses","volume":"31","author":"Kallies","year":"2009","journal-title":"Immunity"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.06.019","article-title":"A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection","volume":"31","author":"Shin","year":"2009","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12967-023-04066-x","article-title":"Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation","volume":"21","author":"Di Zazzo","year":"2023","journal-title":"J Transl Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"879501","DOI":"10.2139\/ssrn.3934240","article-title":"PRDM1 drives human primary T cell hyporesponsiveness by altering the T cell transcriptome and epigenome","volume":"13","author":"Guo","year":"2022","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/s41467-025-56511-8","article-title":"The zinc-finger transcription factor Blimp1\/Prdm1 is required for uterine remodelling and repair in the mouse","volume":"16","author":"Xypolita","year":"2025","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00670-09","article-title":"Blimp-1\/Prdm1 alternative promoter usage during mouse development and plasma cell differentiation","volume":"29","author":"Morgan","year":"2009","journal-title":"Mol Cell Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2008.11.015","article-title":"Blimp1, a conserved transcriptional repressor critical for differentiation of many tissues","volume":"315","author":"John","year":"2009","journal-title":"Exp Cell Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3778","article-title":"Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas","volume":"107","author":"Tam","year":"2006","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.10.030","article-title":"BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma","volume":"18","author":"Mandelbaum","year":"2010","journal-title":"Cancer Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.243","article-title":"Loss of PRDM1\/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma","volume":"31","author":"Xia","year":"2017","journal-title":"Leukemia"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052204","article-title":"Inactivation of the PRDM1\/BLIMP1 gene in diffuse large B cell lymphoma","volume":"203","author":"Pasqualucci","year":"2006","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153860","article-title":"The genetic deletion and protein expression of PRDM1 and its clinical implications in diffuse large B cell lymphoma, A retrospective cohort study in China","volume":"233","author":"Nong","year":"2022","journal-title":"Pathol Res Pract"},{"key":"B50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3760\/cma.j.issn.0529-5807.2018.01.006","article-title":"Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma","volume":"47","author":"Zhang","year":"2018","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"B51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000520070","article-title":"Dysregulated MDR1 by PRDM1\/Blimp1 is involved in the doxorubicin resistance of non-germinal center B-cell-like diffuse large B-cell lymphoma","volume":"67","author":"Qing","year":"2022","journal-title":"Chemotherapy"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0253-2727.2018.12.008","article-title":"PRDM1 expression and its relationship with PI3K\/AKT pathway activation in extranodal NK\/T cell lymphoma-nasal type","volume":"39","author":"Liu","year":"2018","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.254276","article-title":"Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1","volume":"106","author":"Dong","year":"2021","journal-title":"Haematologica"},{"key":"B54","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13045-017-0486-z","article-title":"Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia","volume":"10","author":"Zhu","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.1038\/s41467-022-35469-x","article-title":"PRDM1\/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0605562104","article-title":"BLIMP1 regulates cell growth through repression of p53 transcription","volume":"104","author":"Yan","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B57","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s42003-021-02078-1","article-title":"Mucosal ribosomal stress-induced PRDM1 promotes chemoresistance via stemness regulation","volume":"4","author":"Kim","year":"2021","journal-title":"Commun Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-12-2270","article-title":"Epithelial-to-mesenchymal transition induced by TGF-\u03b21 is mediated by Blimp-1-dependent repression of BMP-5","volume":"72","author":"Romagnoli","year":"2012","journal-title":"Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41598-017-01332-z","article-title":"Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas\/ErbB2 breast cancer invasion","volume":"7","author":"Sciortino","year":"2017","journal-title":"Sci Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02385-4","article-title":"PRDM1 promotes the ferroptosis and immune escape of thyroid cancer by regulating USP15-mediated SELENBP1 deubiquitination","volume":"47","author":"Ma","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033287","article-title":"Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide","volume":"7","author":"Yu","year":"2012","journal-title":"PloS One"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23236","article-title":"Loss of prdm1a accelerates melanoma onset and progression","volume":"59","author":"Iwanaga","year":"2020","journal-title":"Mol Carcinog"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.01.005","article-title":"PRDM1 is directly targeted by miR-30a-5p and modulates the Wnt\/\u03b2-catenin pathway in a Dkk1-dependent manner during glioma growth","volume":"331","author":"Wang","year":"2013","journal-title":"Cancer Lett"},{"key":"B64","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41420-022-01081-7","article-title":"M2-like tumor-associated macrophages transmit exosomal miR-27b-3p and maintain glioblastoma stem-like cell properties","volume":"8","author":"Zhao","year":"2022","journal-title":"Cell Death Discov"},{"key":"B65","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12967-021-02709-5","article-title":"KPNA2 interaction with CBX8 contributes to the development and progression of bladder cancer by mediating the PRDM1\/c-FOS pathway","volume":"19","author":"Zeng","year":"2021","journal-title":"J Transl Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s00432-022-03993-4","article-title":"Blimp-1 is a prognostic indicator for progression of cervical intraepithelial neoplasia grade 2","volume":"148","author":"Saito","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-17-0250","article-title":"BLIMP1 induces transient metastatic heterogeneity in pancreatic cancer","volume":"7","author":"Chiou","year":"2017","journal-title":"Cancer Discov"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-497933","article-title":"PRDM1\/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma","volume":"122","author":"Boi","year":"2013","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-108654","article-title":"PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor","volume":"111","author":"Zhao","year":"2008","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-008-0021-7","article-title":"Nasal NK\/T-cell lymphoma, epidemiology and pathogenesis","volume":"87","author":"Aozasa","year":"2008","journal-title":"Int J Hematol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"435423","DOI":"10.1155\/2015\/435423","article-title":"The genetic deletion of 6q21 and PRDM1 and clinical implications in extranodal NK\/T cell lymphoma, nasal type","volume":"2015","author":"Liang","year":"2015","journal-title":"BioMed Res Int"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-33-7","article-title":"The downregulation of PRDM1\/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK\/T-cell lymphoma, nasal type","volume":"33","author":"Liang","year":"2014","journal-title":"J Exp Clin Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1115128108","article-title":"PRDM1 is a tumor suppressor gene in natural killer cell Malignancies","volume":"108","author":"K\u00fc\u00e7\u00fck","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v112.11.3792.3792","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell Malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-346890","article-title":"Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses","volume":"118","author":"Karube","year":"2011","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adx8105","article-title":"BLIMP1 negatively regulates IL-2 signaling in T cells","volume":"11","author":"Roy","year":"2025","journal-title":"Sci Adv"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)61412-x","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection, a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.05.012","article-title":"PRDM1 levels are associated with clinical diseases in chronic HBV infection and survival of patients with HBV-related hepatocellular carcinoma","volume":"73","author":"Li","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.imlet.2019.07.007","article-title":"PRDM1 rs1010273 polymorphism is associated with overall survival of patients with hepatitis B virus-related hepatocellular carcinoma","volume":"213","author":"Li","year":"2019","journal-title":"Immunol Lett"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22481","article-title":"The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer","volume":"56","author":"Slattery","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"B81","doi-asserted-by":"publisher","first-page":"E5066","DOI":"10.1073\/pnas.1802902115","article-title":"PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids","volume":"115","author":"Liu","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.mcr-13-0286-t","article-title":"Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African Americans","volume":"12","author":"Weige","year":"2014","journal-title":"Mol Cancer Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1093\/9780198727255.003.0050","article-title":"Inclusion of BLIMP-1(+) effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients, a pilot study","volume":"66","author":"Ward-Hartstonge","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801368","article-title":"High-dimensional mass cytometric analysis reveals an increase in effector regulatory T cells as a distinguishing feature of colorectal tumors","volume":"202","author":"Norton","year":"2019","journal-title":"J Immunol"},{"key":"B85","article-title":"MiR-223-3p promotes the proliferation, invasion and migration of colon cancer cells by negative regulating PRDM1","volume":"11","author":"Chai","year":"2019","journal-title":"Am J Transl Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25262","article-title":"PRDM1, a tumor-suppressor gene, is induced by genkwadaphnin in human colon cancer SW620 cells","volume":"117","author":"Kang","year":"2016","journal-title":"J Cell Biochem"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317695929","article-title":"Downregulation of PRDM1 promotes cellular invasion and lung cancer metastasis","volume":"39","author":"Zhu","year":"2017","journal-title":"Tumour Biol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.711772","article-title":"T-cell exhaustion status under high and low levels of hypoxia-inducible factor 1\u03b1 expression in glioma","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e100010","DOI":"10.15252\/embj.2018100010","article-title":"Precocious expression of Blimp1 in B cells causes autoimmune disease with increased self-reactive plasma cells","volume":"38","author":"B\u00f6nelt","year":"2019","journal-title":"EMBO J"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/ng.468","article-title":"A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus","volume":"41","author":"Gateva","year":"2009","journal-title":"Nat Genet"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.05.241","article-title":"Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus","volume":"56","author":"Luo","year":"2013","journal-title":"Mol Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3793","article-title":"Increased cathepsin S in Prdm1(-\/-) dendritic cells alters the T(FH) cell repertoire and contributes to lupus","volume":"18","author":"Kim","year":"2017","journal-title":"Nat Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2014.976627","article-title":"Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus","volume":"48","author":"Luo","year":"2015","journal-title":"Autoimmunity"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-022-00504-z","article-title":"FoxO1 suppresses IL-10 producing B cell differentiation via negatively regulating Blimp-1 expression and contributes to allergic asthma progression","volume":"15","author":"Wang","year":"2022","journal-title":"Mucosal Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.871096","article-title":"Labial gland mesenchymal stem cell derived exosomes-mediated miRNA-125b attenuates experimental Sjogren's syndrome by targeting PRDM1 and suppressing plasma cells","volume":"13","author":"Xing","year":"2022","journal-title":"Front Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-022-02379-3","article-title":"Expression of B lymphocyte-induced maturation protein 1 (Blimp-1) in keratinocyte and cytokine signalling drives human Th17 response in psoriasis","volume":"315","author":"da Costa","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2722-y","article-title":"B lymphocyte-induced maturation protein 1 (BLIMP-1) attenuates autoimmune diabetes in NOD mice by suppressing Th1 and Th17 cells","volume":"56","author":"Lin","year":"2013","journal-title":"Diabetologia"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113072","article-title":"Exosomal lncRNA TUG1 derived from BMSC ameliorate collagen-induced arthritis via BLIMP1-mediated Th17\/Treg balance","volume":"142","author":"Ye","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12974-021-02076-4","article-title":"Dysregulated follicular regulatory T cells and antibody responses exacerbate experimental autoimmune encephalomyelitis","volume":"18","author":"Luo","year":"2021","journal-title":"J Neuroinflamm"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.05.022","article-title":"Sauchinone attenuates inflammatory responses in dendritic cells via Blimp-1 and ameliorates dextran sulfate sodium (DSS)-induced colitis","volume":"527","author":"Xiu","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1159\/000530966","article-title":"Pro-inflammatory of PRDM1\/SIRT2\/NLRP3 axis in monosodium urate-induced acute gouty arthritis","volume":"15","author":"Zhao","year":"2023","journal-title":"J Innate Immun"},{"key":"B102","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10565-024-09932-y","article-title":"PRDM1 promotes nucleus pulposus cell pyroptosis leading to intervertebral disc degeneration via activating CASP1 transcription","volume":"40","author":"Yu","year":"2024","journal-title":"Cell Biol Toxicol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13073-025-01541-6","article-title":"Identification of a PRDM1-regulated T cell network to regulate atherosclerotic plaque inflammation","volume":"17","author":"Jin","year":"2025","journal-title":"Genome Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780198870197.003.0052","article-title":"Thyroiditis","volume":"348","author":"Pearce","year":"2003","journal-title":"N Engl J Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2015.08.009","article-title":"PRDM1 expression via human parvovirus B19 infection plays a role in the pathogenesis of Hashimoto thyroiditis","volume":"46","author":"Wang","year":"2015","journal-title":"Hum Pathol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1219462110","article-title":"Inducible deletion of the Blimp-1 gene in adult epidermis causes granulocyte-dominated chronic skin inflammation in mice","volume":"110","author":"Chiang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/ng.479","article-title":"Genetic variants at CD28, PRDM1 and CD2\/CD58 are associated with rheumatoid arthritis risk","volume":"41","author":"Raychaudhuri","year":"2009","journal-title":"Nat Genet"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.04.040","article-title":"Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies","volume":"145","author":"Ellinghaus","year":"2013","journal-title":"Gastroenterology"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz010","article-title":"CD4+ tissue-resident memory T cells expand and are a major source of mucosal tumour necrosis factor \u03b1 in active Crohn's disease","volume":"13","author":"Bishu","year":"2019","journal-title":"J Crohns Colitis"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2014.10.010","article-title":"Systemic sclerosis, recent insights","volume":"82","author":"Elhai","year":"2015","journal-title":"Joint Bone Spine"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210645","article-title":"Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis","volume":"76","author":"Terao","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012714","article-title":"Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy","volume":"139","author":"Yoshikawa","year":"2022","journal-title":"Blood"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013209","article-title":"Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells","volume":"9","author":"Battram","year":"2025","journal-title":"Blood Adv"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2407","article-title":"Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second Malignancies after Hodgkin's lymphoma","volume":"17","author":"Best","year":"2011","journal-title":"Nat Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1856181\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:02:10Z","timestamp":1781787730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1856181\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":115,"alternative-id":["10.3389\/fimmu.2026.1856181"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1856181","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"article-number":"1856181"}}